Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in Ukraine

Dudnyk, A.; Hempel, M.; Lytvyniuk, O.; Liudkevych, H.; Matsera, V.; Nikitchenko, T.; Blyzniuk, S.; Molina-Moya, B.; Preyer, R.; Domínguez, J.

Домівка
→
Кафедра фтизіатрії з курсом клінічної імунології та алергології
→
Наукові публікації каф. фтизіатрії
→
Перегляд матеріалів

dc.contributor.author	Dudnyk, A.	en
dc.contributor.author	Hempel, M.	en
dc.contributor.author	Lytvyniuk, O.	en
dc.contributor.author	Liudkevych, H.	en
dc.contributor.author	Matsera, V.	en
dc.contributor.author	Nikitchenko, T.	en
dc.contributor.author	Blyzniuk, S.	en
dc.contributor.author	Molina-Moya, B.	en
dc.contributor.author	Preyer, R.	en
dc.contributor.author	Domínguez, J.	en
dc.date.accessioned	2025-03-08T11:33:41Z
dc.date.available	2025-03-08T11:33:41Z
dc.date.issued	2024
dc.identifier.citation	Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in Ukraine / A. Dudnyk, M. Hempel, O. Lytvyniuk [et al.] // Therapeutic Advances in Respiratory Disease. – 2024. – Vol. 18. – P. 1–18.	en
dc.identifier.other	DOI: 10.1177/17534666241249841	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/7130	en
dc.description.abstract	Ukraine remains a high World Health Organization priority country for drug-resistant tuberculosis (TB). Rifampicin-resistant TB (RR-TB) has a more protracted, more complicated, and more expensive treatment. In 2021, Ukraine reported 4025 RR-TB cases – 5.4 times more (751) than all 30 European Union/ European Economic Area countries together. The objective of the study was to determine the diagnostic accuracy of line probe assay (LPA), AID Autoimmun Diagnostika GmbH, for detecting resistance to anti-TB drugs and its clinical application for selecting treatment regimens.	en
dc.language.iso	en	en
dc.publisher	Therapeutic Advances in Respiratory Disease	en
dc.subject	drug-resistant tuberculosis	en
dc.subject	line probe assay	en
dc.subject	molecular diagnostics	en
dc.subject	TB treatment	en
dc.title	Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in Ukraine	en
dc.type	Article	en